| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f9b85facfe9e7e45612c990e4e1492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13cbcd07aeaf7f8b4d3f55f0c8169959 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66 |
| filingDate |
1999-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a03aa3ff211a4775099f6b9acdab3bb |
| publicationDate |
2000-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0013027-A1 |
| titleOfInvention |
Diagnosis of atherosclerosis by 'face' measurement of heparin |
| abstract |
The present invention provides methods for measuring endogenous heparin in a mammal at levels that were previously undetectable. The present invention further features methods for assessing the risk for and assessing the progression of atherosclerosis and methods for treating or inhibiting the progression of atherosclerosis. The invention also features methods for monitoring plasma heparin levels in subjects undergoing heparin treatment. Additionally, the present invention provides kits for assaying for heparin in biological samples. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2880951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2397190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006077317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2085780-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7575930-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105603046-A |
| priorityDate |
1998-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |